| Literature DB >> 32547187 |
Haimanot Melese1, Abayneh Alamer1, Melaku Hailu Temesgen1, Fetene Nigussie2.
Abstract
The purpose of this review was to summarize the current best evidence for the effectiveness of Kinesio Taping in reducing pain and increasing knee function for patients with knee osteoarthritis. A comprehensive search of literature published between 2014 and 2019 was conducted using the following electronic databases: PubMed, Google Scholar, Physiotherapy Evidence Database (PEDro), Science Direct, and Scopus. Only randomized controlled trials evaluating the effect of Kinesio Taping on knee osteoarthritis were included. PEDro was used to assess the risk of bias of included trials. This study was reported according to the guideline of the PRISMA statement. The methodological quality of the studies was done using the PEDro scale and GRADE approach. The overall quality of evidence was rated from moderate to high. Eighteen randomized trials involving 876 patients were included. The present systematic review demonstrated that there were significant differences between Kinesio Taping groups and control groups in terms of visual analog scale (VAS), Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC) scale and flexion range of motion. Kinesio Taping is effective in improving pain and joint function in patients with knee OA.Entities:
Keywords: Kinesio Taping; knee joint; osteoarthritis; systematic review
Year: 2020 PMID: 32547187 PMCID: PMC7266391 DOI: 10.2147/JPR.S249567
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram.
Notes: Adapted from Moher et al.53
Summary of Included Randomized Controlled Trials
| Authors (Year) | Patient Characteristics, Sample Size, Mean Age | Intervention | Frequency and Mean Follow-Up Time | Outcome Measures |
|---|---|---|---|---|
| Anandkumar (2014) | Source: 40 outpatients | EG: therapeutic | Taping for 30 min | -VAS |
| Cho (2015) | Source: 46 volunteer | EG: therapeutic | Taping for 60 min | - Pain-free ROM of the knee joint (active ROM) |
| Kocyigit (2015) | Source: 41 outpatients with | EG: therapeutic | Repeated every 4 days, 3 times in total | - Pain intensity with activity and at night (VAS) |
| Lee (2016) | Source: 30 elderly patients | EG: KT | 3 times/week for 4 weeks. | - Pain intensity (VAS) |
| Kaya et al (2017) | Source: 39 outpatients with | EG: therapeutic | 12–16 days in total | -Pain intensity (VAS at rest), - Functional disability |
| Wageck (2016) | Source: 76 outpatients with | EG: a multilayer | Taping for 4 days, follow-up for extra 15 days | - Functional disability (WOMAC) |
| Dhanakotti (2016) | Source: 30 patients with | EG: KT with 40% stretch of its | 3 times/week for 3 weeks | - Pain intensity (NPRS) |
| Malgaonkar (2014) | Source: 40 subjects with | EG: therapeutic | 3 times/week for 2 weeks | - Pain intensity (VAS) |
| Donec and Kubilius (2019) | Source: 187 subjects with OA (EG=94, CG=93) | EG: two Y-shaped KT strips | 2 times/week for 4 weeks | - Numeric Pain Rating Scale |
| Taheri et al (2017) | Source: 36 patients with knee OA (EG=20, CG=16) | EG: taping (in first 3 weeks) combined with exercise therapy | 6 weeks | -VAS |
| Park and Kim (2018) | Source: 50 patients with knee OA (EG=25, CG=25) | EG: non-elastic taping | Not determined | - NRS |
| Castrogiovanni et al (2016) | Source: 66 patients with OA (exercise group=19, Exercise and KT with tension=19 and exercise and KT without tension=19 Mean age: G1= 63.90 (15.4), G2=64.20 (14.5) G3=64.80 (14.2) | -Exercise group | 3 months | -VAS |
| Rahlf et al (2018) | Source: 131 patients with OA(EG=44, placebo=43, CG=44) | EG: taping at knee joint. | Consecutive 3 days | -ROM |
| Nwe et al (2019) | Source: 60 patients with OA (EG=30, CG30) | EG:KT plus conventional exercise | 1 time/week for 3 weeks | -VAS, |
| Tripathi et al (2017) | Source: 30 patients with OA(EG=15, CG=12) | EG: KT plus standard conventional therapy | 1 time/week for 3 weeks | -NRS scale |
| Hayati et al (2019) | Source: 84 patients with OA of knee (EG=37, CG=29, sham group=18) | EG: NSAID therapy and KT | 3 times a week at 1-day interval | -VAS |
| Hakakzadeh et al (2019) | Source: 30 patients with OA | EG: KT with 15–25% tension | 3 days duration | -VAS |
| Sedhom (2016) | Source: 40 females with | EG: KT plus CET | 3 times /week for | -VAS |
Abbreviations: OA, osteoarthritis; KT, Kinesio Taping; CPT, conventional physical therapy; VAS, visual analog scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; KWOMAC, Korean Western Ontario and McMaster Universities Osteoarthritis Index; ROM, range of motion; NPRS, Numeric Pain Rating Scale; NSAID, non-steroidal anti-inflammatory drugs; CET, conventional exercise; EG, experimental group; CG, control group; PUT, pulsed ultrasound therapy; MWM, Mulligan’s movement with mbilization.
Quality Assessment of Controlled Intervention Studies
| Pedro Scale Items | Kocyigit M et al, 2015 | Anandkumar et al, 2014 | Cho et al, 2015 | Taheri et al, 2017 | Kaya et al, 2017 | Park and Kim, 2018 | Nwe et al, 2019 | Tripathi et al, 2017 | Hayati et al, 2019 | Donecand Kubilius et al, 2019 | Giusepp et al, 2016 | Lee et al, 2016 | Rahlf et al, 2019 | Sedhom, 2016 | Anandkumar et al, 2014 | Dhanakotti et al, 2016 | Wageck et al, 2016 | Abolhasaniet al, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eligibility | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Random allocation | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes |
| Concealed allocation | Yes | Yes | Yes | Yes | Yes | No | Yes | No | Yes | Yes | Yes | No | No | No | No | No | Yes | Yes |
| Baseline comparability | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Blind participants | No | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes |
| Blind therapist | Yes | No | No | No | No | No | No | No | Yes | No | No | No | No | No | No | No | No | No |
| Blind assessor | No | No | No | No | No | Yes | No | No | Yes | Yes | No | No | No | No | No | Yes | Yes | No |
| Adequate follow-up | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No |
| Intention-to-treat analysis | Yes | Yes | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Between-group comparisons | Yes | Yes | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Point estimates and variability | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | No | No | Yes |
| Total quality score out of 10 | 8 | 8 | 5 | 6 | 8 | 6 | 8 | 7 | 9 | 9 | 7 | 5 | 7 | 6 | 7 | 7 | 7 | 7 |
| Graded approach | High | High | Moderate | High | High | High | High | High | High | High | High | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate |